Precision Biosciences Inc

Ownership Transactions Reported by 19 Insiders

Symbol
DTIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
302 East Pettigrew Street, Suite A 100, Durham, NC

Insiders trading volume in the past year

Precision Biosciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novartis Pharma Ag 10%+ Owner $4.59M Jun 15, 2022
Derek Jantz Chief Scientific Officer, Director $1.51M Jun 7, 2022
Michael Amoroso President and CEO, Director $750K -$200K -21% Nov 2, 2025
R. Matthew Kane President and CEO, Director $749K Jun 7, 2021
John Alexander Kelly Chief Financial Officer $502K -$41.3K -7.61% Nov 2, 2025
J. Jefferson Smith Chief Research Officer $470K -$50K -9.62% Jun 2, 2025
Geno J. Germano Director $217K +$33.4K +18.2% May 27, 2025
Stanley Frankel Director $201K +$13.4K +7.14% Sep 26, 2025
Shari Lisa Pire Director $184K May 27, 2025
Dario Scimeca General Counsel and Secretary $183K -$48.4K -20.9% Nov 2, 2025
Samuel C. Wadsworth Director $161K Jun 4, 2024
Kevin Buehler Director $109K +$63.3K +138% Jun 25, 2025
Melinda Brown Director $107K +$36.3K +51% Sep 22, 2025
Alan List Chief Medical Officer $56.4K May 1, 2024
David S. Thomson Chief Operating Officer $41.3K Jun 23, 2021
Shane Barton VP & Corporate Controller $12.4K Jun 7, 2023
Fayaz Khazi CEO of Elo Life Systems $8.88K Jun 7, 2021
Raymond F. Schinazi Director May 10, 2022
Shalini Sharp Director May 10, 2021

Recent Insider Transactions by Companies or Individuals for Precision Biosciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.